Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NK NantKwest Inc

32.49

0.00 (0.00%)

Last Updated: 20:00:00

Delayed by 15 minutes

NantKwest surges on FDA clearance to expand Phase 1 trial for COVID-19 vaccine

To read the full story on Seeking Alpha, click here.

NantKwest (NASDAQ:NK)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more NantKwest Charts.

NantKwest (NASDAQ:NK)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more NantKwest Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

NantKwest Inc News

More NantKwest Inc News Articles

Clean Vision (QB)

Baron Capital Enterprise (CE)

Kraig Biocraft Laborator... (QB)

FOXO Technologies

Lehman Brothers Financial (CE)

Eyecity Com (PK)

Revance Therapeutics

TPT Global Tech (CE)

Lightwave Logic

RespireRx Pharmaceuticals (CE)

Rennova Health (CE)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions